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Exploration of ligand binding 
modes towards the identification 
of compounds targeting HuR: a 
combined STD-NMR and Molecular 
Modelling approach
Francesca Vasile  1, Serena Della Volpe1,2, Francesca Alessandra Ambrosio3, Giosuè Costa  3, 
M. Yagiz Unver4, Chiara Zucal5, Daniela Rossi2, Emanuela Martino6, Alessandro Provenzani5, 
Anna K. H. Hirsch4,7, Stefano Alcaro  3, Donatella Potenza1 & Simona Collina  2
Post-transcriptional processes have been recognised as pivotal in the control of gene expression, 
and impairments in RNA processing are reported in several pathologies (i.e., cancer and 
neurodegeneration). Focusing on RNA-binding proteins (RBPs), the involvement of Embryonic Lethal 
Abnormal Vision (ELAV) or Hu proteins and their complexes with target mRNAs in the aetiology of 
various dysfunctions, has suggested the great potential of compounds able to interfere with the 
complex stability as an innovative pharmacological strategy for the treatment of numerous diseases. 
Here, we present a rational follow-up investigation of the interaction between ELAV isoform HuR 
and structurally-related compounds (i.e., flavonoids and coumarins), naturally decorated with 
different functional groups, by means of STD-NMR and Molecular Modelling. Our results represent 
the foundation for the development of potent and selective ligands able to interfere with ELAV–RNA 
complexes.
Post-transcriptional modifications have a crucial role in regulating gene expression by shaping the fate of RNA 
transcripts in their journey from the nucleus (i.e., alternative splicing, poly-adenylation, nuclear export) to the 
ribosome (i.e., cytoplasmic localisation, stability, translation rate). Dysfunctions within these routes may be 
directly involved in several pathologies, such as neurodegenerative diseases, inflammation and cancer1–5.
In this context, RNA-binding proteins (RBPs), have been recognised to be play a prominent role as they affect 
the fate of target messenger RNAs (mRNAs) coding for proteins pivotal in key cellular functions1–5.
Embryonic Lethal Abnormal Vision (ELAV) or Hu proteins are among the better characterised RBPs with 4 
human mammalian isoforms: ubiquitous HuR, and HuB, HuC and HuD prevalently expressed in the nervous 
system (nELAVs)6. These proteins share a high degree of sequence homology (70–85%): they contain three RNA 
recognition motif-type (RRM) domains, each approximately 90 amino-acid in length7; the first two consecutive 
domains (RRM1 and RRM2) are near the N-terminus and link to the third domain (RRM3) by an unconserved 
hinge region, responsible for the nuclear/cytoplasmic shuttling occurring after protein activation8–10. RRM1 and 
RRM2 directly interact with target transcripts through highly conserved ribonucleoprotein (RNP) sequences 1 
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and 2, formed by 8 and 6 amino acids, respectively11,12 while RRM3, aside from binding the poly(A) tail of target 
mRNAs, has a crucial role in the homo- and heteromultimerisation of ELAV proteins (Fig. 1)13–15.
The interaction of the four mammalian ELAV proteins with many mRNAs, gives rise to various ELAV pro-
tein−RNA complexes, characterised by different physiological roles. As a consequence, ELAV proteins have a 
potential as pharmacological targets in several pathologies and compounds able to interfere with ELAV–RNA 
complexes may lead to different effects.
Particularly, it has been demonstrated that the RNA-binding protein HuR is highly abundant in many cancers 
and it may either be a marker for malignancy or have an oncogenic role in numerous tumor systems including 
breast, ovarian, and colon16–18. In fact, numerous HuR‐regulated mRNAs encode proteins implicated in carcino-
genesis19. For this reason, HuR can be considered a promising candidate target for governing gene regulatory 
mechanisms. Specifically, it was shown that HuR is upregulated and dysregulated in cancer cells, in part, through 
post-transcriptional gene regulation19,20. Among the small natural products that have been reported to inhibit 
HuR function, it is worth mentioning MS-444, since it has been shown to prevent translocation of HuR (and its 
associated mRNA cargos) to the cytoplasm. In a number of tumor cells, HuR inhibition by MS-444 leads to a 
dose-dependent reduction in cell proliferation by promoting apoptosis21. The majority of compounds interact-
ing/interfering with HuR−RNA complexes have been discovered by screening a large number (or a library) of 
commercially available compounds with high-throughput screening (HTS) approaches and using various bio-
logical assays based on different detection technologies21,22. Among them, dihydrotanshinone (DHTS), which 
is a nanomolar disruptor of HuR–RNA binding23, has potent HuR-dependent antitumor activity in vivo and is 
able to inhibit HuR multimerization24,25. Starting from the DHTS scaffold, medicinal-chemistry efforts led to the 
discovery of a series of small molecules called Tanshinone Mimics (TMs) with improved affinity and potency 
compared to DHTS26. Summing up, and going beyond the state of the art of HuR modulators available so far, the 
identification of the key druggable pockets on the surface of HuR is the essential milestone for discovering new 
molecular scaffolds.
As a part of our ongoing efforts in this field, we had already demonstrated the importance of the four RNP 
sequences in binding and stabilising a target transcript RNA by means of real-time quantitative PCR27, molec-
ular modelling28 and advanced NMR techniques (Saturation-Transfer Difference, STD, and Diffusion-Ordered 
Spectroscopy, DOSY)29.
In the present work, we set out to study the interaction between HuR and a number of compounds performing 
a systematic study which combines a ligand-based NMR technique, namely STD-NMR, with a molecular model-
ling study. It is well known that STD-NMR can be used as an epitope mapping device to describe the target–ligand 
interactions30–32 and it can be applied to weak and transient protein–ligand complexes that are difficult to study by 
other structural methods33,34. We compared results of STD-NMR with molecular dynamics and docking simula-
tions, thus affording an improved understanding of ligand–HuR interactions. Despite the high protein mobility 
and width of the protein–RNA interface, the combination of NMR and in silico studies resulted to be a reliable 
tool for understanding HuR-ligand binding modes35,36. The exploitation of these interactions lays the foundation 
for the design of ad hoc molecules endowed with HuR–RNA complex interfering properties.
Results
Selection of compounds, solubility and stability assessment. Our previous docking results 
had revealed that a series of natural products, i.e. epigallogatechin gallate, quercetin, okicenone, myricetyn, 
DHTS, MS-444 and others (described in SI), interact with HuR in the same regions as the target RNAs, more 
specifically with the RNP1 and RNP2 sequences of the RRM1 and RRM2 domains of the protein22. Based on these 
preliminary data, with the aim to study the ligand-HuR interaction, we collected a small series of compounds of 
natural origin, namely flavones, flavonols, flavan-3-ols and coumarins, naturally decorated with different func-
tional groups, as well as some unrelated compounds with similar features and a high degree of structural diversity 
(Figs 2, 3). We then tested their solubility and stability in the buffer and time-ranges required by STD-NMR 
experiments (24–48 hours). In detail, a 1 mM solution of each compound was dissolved in a 20 mM deuterated 
phosphate buffer within a 5.0–7.4 pH range (where necessary, a DMSO-d6 percentage ≤10% was added), at a 
283–303 K temperature range and studied by preliminary 1H-NMR experiments.
Among the tested molecules, we selected 13 soluble and stable compounds (Fig. 3) and used them in 
STD-NMR experiments to explore the ligand-protein interaction mode.
Figure 1. ELAV domains and their involvement in protein function.
www.nature.com/scientificreports/
3SCiEntifiC REpoRts |  (2018) 8:13780  | DOI:10.1038/s41598-018-32084-z
NMR interaction studies with HuR. Prior to the interaction study with HuR, 1H, COSY, TOCSY, HSQC 
and NOESY spectra of the selected compounds were recorded in the proper deuterated phosphate buffer solution 
(pH range 5.8–7.4) at 298 K and 283 K. The assignment of all compounds is reported in SI.
STD-NMR is one of the most widespread NMR techniques used to study the interactions between small lig-
ands and macromolecules37,38. This method is based on the transfer of saturation from the protein to the bound 
ligand which in turn, by exchange, is moved into solution where it is detected. During the period of saturation 
(saturation time), the magnetisation gradually moves from the protein to the protons of the ligand when it binds 
to the target. The saturation time is chosen taking into account the efficiency of saturation transfer from protein 
protons during the bound state (intermolecular protein–ligand NOEs) and the rate of accumulation of saturated 
ligand molecules in the free state. Long saturation times permit to map all ligand contacts. This saturation pro-
cess is very efficient, so the modulation of the ligand signal induced by the protein is readily detected, even in 
the presence of a large excess of ligand. The ligand protons nearest to the protein are most likely to be saturated 
to the highest degree, and therefore have the strongest signal in the one-dimensional STD spectrum. The ligand 
protons located further away are saturated to a lower degree, and their STD intensities are weaker. Therefore, the 
degree of saturation of individual ligand protons (expressed as absolute-STD %) reflects their proximity to the 
protein surface and can be used as an epitope-mapping method to describe the target–ligand interactions39,40. 
STD-NMR spectra were initially acquired with varying saturation times from 0.98 s to 2.94 s and using different 
ligand–protein ratios (from about 500:1 to 1000:1). This large molar excess of ligand was employed in order to 
preclude the perturbations of absolute STD intensities due to rebinding effects, which would impede the correct 
determination of the group epitope mapping. Additionally, negative controls were performed to avoid artefacts 
due to the presence of signals in the blank. The optimal conditions found entail the use of 2.94 s, with high ligand/
protein ratios (around 1000:1) for all compounds and exploiting the Watergate sequence for water suppression.
The absolute STD percentages of each ligand protons were quantified in order to analyse their proximity to the 
protein surface (short protein–ligand distances produce a strong intensity of the corresponding STD signal). On 
the other hand, also relative STD percentages were calculated for each compound, by normalising all measured 
STD intensities against the most intense signal (which is arbitrarily assigned a value of 100%). The obtained group 
epitope mapping then illustrates which chemical moieties of the ligand are key for molecular recognition in the 
binding site.
STD-NMR spectra were acquired and processed accordingly for all 13 compounds and showed that 12 out of 
the 13 compounds studied interact with HuR displaying different intensities and epitopes of interaction. Given 
the difficulty of determining KD values for each compound with STD-NMR experiments due to the compounds 
poor solubility, we analysed the absolute STD data following two different keys: (a) the intensity of the STD sig-
nals (indicative of the proximity to the protein) and (b) the number of interactions for each ligand.
By reporting the number of the signals and related intensity of each compound, Table 1 gives a picture of their 
interaction with target HuR. Most of the compounds studied are characterised by a weak interaction with the 
protein within the absolute STD range of 0.4–0.1% and only a few ligands present STD signals exceeding the unit 
value (Table 1). Remarkably, compound 9 gives the highest number of interactions, while 6 is characterised by 
fewer and weaker interactions with the protein.
Moreover, compound 5 has the highest number of very strong interactions and several of medium and low 
intensity. On the other hand, the STD-NMR spectra for 13 and HuR showed absence of signal, indicative of lack 
of interaction between the two entities.
In addition to absolute STD% to evaluate the binding epitope of each compound, we calculated relative STD% 
as shown in Fig. 4 conveyed by colour code; black dots are used to indicate the most intense signal arbitrarily 
assigned the value of 100% relative STD. Subsequently, dark red dots represent relative STD over 80%, orange 
dots over 40%, and lime green dots under 40%; all are relative to the most intense STD signal. Additionally, in 
Fig. 5, we report the 1H and STD spectra for compound 5 and the corresponding coloured dots for relative STD% 
according to the colour code just described.
In silico studies on HuR protein. For the preliminary selection of the compounds to be used in our study, 
we utilised the rigid docking approach previously published22, which allowed us to quickly evaluate their poten-
tial. In order to better characterise the results obtained through STD-NMR, we decided to exploit a complemen-
tary in silico approach, which is computationally more demanding but enables a more detailed description of the 
ligand–protein behaviour in solution.
The protein crystal structure represents one of the many possible substates of the protein and, in most cases, 
the overall topology of the folded state is conserved, but a different orientation of even a single side chain in the 
binding site can significantly influence docking results41. Thus, in order to consider all conformational states of 
Figure 2. General structures of the naturally-occurring compounds selected; the arrows define the possible 
positions of decoration.
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HuR and to investigate potential protein rearrangement, we submitted the HuR RRM domain–RNAc-fos complex 
(PDB code: 4ED5) to 500 ns of Molecular Dynamics simulations (MDs)42. The result trajectory was clustered 
with respect to the Root Mean Square Deviation (RMSD), affording ten representative structures, which we used 
for the following docking studies. By applying this approach, we were able to reproduce the results previously 
reported on the two main conformational states of the HuR RRM domains, “open” and “closed”24,43. We analysed 
how the ligands can bind the two states and we observed that the STD contacts better fit with the “closed” state 
of HuR. Here, we will describe the interaction of each ligand with a HuR snapshot corresponding to the “closed” 
conformation. Molecular-recognition studies revealed that 12 of the 13 considered compounds interact with the 
same region in the HuR interaction site (Figs 6b and 7), in a deep pocket of domains RRM1 and RRM2, while 
Figure 3. Structures of the naturally occurring products ultimately subjected to the study.
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Compound
Number of interacting protons
Absolute STD % ranges
>1 1.0–0.9 0.8–0.7 0.6–0.5 0.4–0.2 <0.2
1 2 4
2 2 3 2
3 2 1 5
4 1 3 1
5 3 5 1
6 1 6
7 1 2 2
8 2 2
9 2 2 1 1 7
10 1 1 5
11 1 2 5 5
12 1 2 1 3
13 no signal shown
Table 1. Compound and related number of interacting protons within listed absolute STD range.
Figure 4. Group epitope mapping is highlighted for each compound. Relative STD percentages are conveyed 
by colour code: black dots indicate the most intense signal (100% relative STD), dark red dots over 80%, orange 
dots over 40%, and lime green dots under 40% relative to the most intense STD signal.
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compound 13 appears to interact with their external surface (docking poses divided by class of compound are 
reported in Fig. 7, while poses for single compounds are reported in SI). All contacts between the HuR binding 
site and ligands will be identified and catalogued in terms of hydrophobic contacts, hydrogen bonds and cation-π 
interactions.
Furthermore, it is worth noting that the HuR “closed” form thus explained could exceed the sole descriptive 
purpose and be exploited as a model for future structure-based virtual screening (SBVS) studies using different 
compound libraries, as already implemented on different targets in our previous investigations44,45, in order to 
identify new ligands interfering with the HuR–RNA complex.
Discussion
STD-NMR and molecular modelling results have been compared to gain a more detailed picture of the ligand–
protein interactions. As previously mentioned, MD simulations of HuR clearly showed that the protein can exist 
in two prevalent structural conformations: the “open” conformation and the “closed” one; the comparison of 
experimental STD-NMR and theoretical docking results, led us to hypothesise that the “closed” conformation is 
predominant in presence of interacting ligands.
For simplicity purposes, we present all the following considerations in the next section as a comparison of 
the results divided by class of compound. Combined NMR and docking data for all interacting compounds are 
Figure 5. 1H and STD spectrum of compound 5; coloured dots convey relative STD % according to the 
following colour code, black dots indicate the most intense signal arbitrarily assigned the value of 100% relative 
STD; dark red dots represent relative STD over 80%, orange dots over 40%, and lime green dots under 40%; all 
relative to the most intense STD signal.
Figure 6. (a) 3D representation of HuR RRM1 and RRM2 domain–RNAc-fos complex in its “closed” 
conformation; (b) Superimposition of all studied compounds in the “closed” conformation of the HuR–
RNA interaction site. HuR and RNAc-fos are represented as light-orange and orange cartoon, respectively; all 
compounds are depicted as green sticks.
www.nature.com/scientificreports/
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reported in supporting information, where for each compound, the intensity of the STD signal of each proton is 
compared with the number of the interactions observed in silico.
Concerning Flavan-3-ols or catechins (1–3), the three compounds considered differ only in the substitution 
and stereochemistry of the carbon atom in position 3; in particular, 2 and 3 only differ in the configuration of 
carbon 3 (respectively, (R) and (S)), while 1 (R) hosts an additional aromatic ring. STD experiments showed that 
the protons in positions 6 and 8 of the chroman-3-ol nucleus (structures in Figs 4a and SI) are mainly involved in 
their interaction with HuR. For all compounds, the aromatic nucleus in position 2, and the additional aromatic 
ring (gallate ester) in position 3 for compound 1, participate in the interaction, even though to a lesser degree. 
Docking results show that all compounds interact in the same region of the HuR interaction site (Fig. 7a); in par-
ticular, we observed that all aromatic rings in position 2 overlap and are involved in a cation-π interaction with 
Arg97. On the other hand, the chroman-3-ol nucleus of 1 does not show overlapping interactions with the same 
nucleus of compounds 2 and 3, as it projects towards Phe65, establishing hydrophobic interactions, whereas, the 
chroman-3-ol nucleus of compounds 2 and 3 overlaps with the gallate ester moiety of 1. Moreover, considering 
the evidence that 2 and 3 show very similar interactions, it is fair to assume that, within their scaffold, the absolute 
configuration at carbon 3 does not play a relevant role in the interaction with target HuR.
Within the flavonol compound class (4 and 5), the chromone-3-ol nucleus and the aromatic ring in position 
2 are highlighted as interacting regions (Figs 4b and SI), in line with the STD results obtained with the previous 
class (Flavan-3-ols). Furthermore, in both cases, the additional sugar rings in position 3 reinforce the interaction 
with the protein. In silico results show compounds 4 and 5 bind to HuR by interacting with the same residues 
(Arg153, Tyr63, Arg97, Pro98). However, the second sugar moiety of compound 5 (rhamnose) establishes addi-
tional hydrophobic interactions with Lys55 and Ile52 and a hydrogen bond with Tyr63 of RRM1, justifying a 
slight deviation from the binding site for compound 5 (Fig. 7b); this is also in accordance with the strong STD 
signals seen for this sugar moiety.
Different to the first two classes of flavonoids, the chromone nucleus of Flavones (6 and 7) shows almost com-
plete absence of STD peaks (Figs 4c and SI), which denotes a scarce contact with the protein, while, albeit weak, 
the interaction of the phenols in position 2 is still observed. The sugar moieties interact with the target protein 
HuR with different intensities, namely 1% absolute STD for the proton in position 2″ of 7, and 0.25% abso-
lute STD for 4′′′ of 6. Accordingly, 6 and 7 show different binding poses and very limited common interactions 
(Fig. 7c), as compound 7 elongates in the site forming hydrogen bonds with Asn82, Asn 25, Arg97 and Pro98, 
while compound 6 adopts a rather closed conformation and interacts with Arg153 and Ile103 of RRM2 and Tyr63 
and Lys55 of RRM1.
Focusing on coumarins (8 and 9), within STD experiments, compound 8 displayed few and weak interactions 
with HuR, presumably due to its small size. Furthermore, the sugar ring in position 6 does not improve its contact 
with HuR (Figs 4d and SI). In contrast, the STD spectrum of 9 showed a large number of intense peaks relative to 
both the coumarin nucleus and the conjugated moiety on the right-hand side (Figs 4d and SI). Moreover, the STD 
peaks relative to the noviose moiety, although weaker, convey its contribution to increasing the interaction with 
Figure 7. 3D representation of compounds divided by compound class in the HuR–RNA interaction site: (a) 
compounds 1, 2, 3 (blue, green and yellow sticks, respectively); (b) compounds 4 and 5 (green and violet sticks 
respectively); (c) compounds 6 and 7 (blue and green, respectively); (d) compounds 8 and 9 (violet and green 
sticks); (e) compounds 10, 11 and 12 (yellow, green, blue sticks, respectively); (f) compound 13 shown as green 
sticks; HuR protein shown as orange cartoon60.
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the target HuR. Accordingly, docking studies reveal compounds 8 and 9 fit differently into the HuR interaction 
site, most likely due to their different size (Fig. 7d). In particular, the unsaturated conjugated regions of 9 protrude 
all along the considered interaction site, establishing hydrophobic interactions with Ile132 and Ile133 of RRM2 
and Lys92, Val93 and Ser94 of RRM1 and hydrogen bonds with Arg153 of RRM2 and Asn25 of RRM1 with the 
sugar portion projecting towards the solvent, providing additional interactions with Lys55 of RRM1.
As mentioned above, compounds 10–13 (Fig. 4e) are structurally different to both the original ones and the 
others involved in the study. For all of them, STD-NMR spectra show that the main interactions are achieved 
through the presence of unsaturated conjugated regions. Related docking results show compounds 10–12 occupy 
the deep part of the interaction site (Fig. 7e), as they appear to be involved in hydrogen-bond interactions with 
amino acids lining the deep part of the pocket such as Arg97, Arg131, Arg153, Asp105.
Finally, the STD spectrum of compound 13 in presence of HuR shows no signals indicating the absence of 
interactions. Within docking studies against the “closed” conformation of the protein, compound 13 only appears 
to interact with the external surface of the HuR–RNA interacting site probably due to steric hindrance, and does 
not overlap with the same region interacting with all other molecules. As a consequence, the in vitro interaction 
may be too weak to fall in the detection range of STD-NMR.
In addition to the considerations reported and discussed inside each compound class, it is worth remarking 
that recurring patterns can be recognised within the entirety of the compound collection investigated or wider 
subgroups.
Particularly, among flavonoid derivatives, flavan-3-ols and flavonols (Figs 4a,b, 7a,b and SI), both STD-NMR 
epitopes and in silico data show similar data, while flavones (Figs 4c, 7c and SI) show different behaviours. This 
has been attributed to both the difference in substitution positions (position 3 for the first two classes, versus 6 
and 8 for flavones) and in sugar linking (O- and C-glycoside, respectively), which increase the rigidity of the 
flavone scaffold.
Moving on to comment on the whole library, the importance of unsaturated conjugated regions as well as 
aromatic rings in the interaction with HuR has been noted throughout both STD-NMR and molecular modelling; 
additionally, these moieties seem to fit in repeated regions, and thus show hydrophobic interactions with repeated 
residues, namely Ile23, Asn25, Ser94, Ile133 and Arg153. Moreover, concerning the sugar moiety counterparts, 
we observed that the sugar rings directly attached to the aromatic ring of compounds 4, 5, 6, 7 and 8 and the 
quinic acid moiety of 10, overlap in the same region of the HuR binding site, establishing contacts with repeated 
residues (Arg97, Pro98, Ser99 and Ile 103).
To sum up, the results we obtained thus far evidenced that all interacting compounds interact with repeated 
residues of RNP1 and RNP2 of RRM1 domain; compounds 1–12 interact deep in the interaction site, while 13 
protrudes more outwardly towards the solvent. Furthermore, our study corroborates the already reported obser-
vation that interacting compounds could stabilise a closed conformation of the HuR binding site22,26,46.
Conclusions
The acknowledgement of the crucial role of post-transcriptional processes in the control of gene expression and 
their connection to various diseases has opened up a new fascinating route for discovering new drugs. RNA 
binding proteins, and particularly those belonging to the ELAV family, can affect the fate of target mRNAs whose 
coded proteins are fundamental for key cellular functions22,47. Interfering compounds may specifically affect 
the fate of ELAV protein−mRNA complexes at various levels, in both the nucleus and the cytoplasm, and also 
depending on the transcript targeted, as well as on other modulating factors (i.e., other RBPs and miRNAs). 
Since compounds interfering with all ELAV proteins may give rise to several effects, the tailored design and 
tissue-targeted delivery of selective compounds will be essential. To date, little structural information are available 
and a rational drug-design approach is difficult to employ at this stage and this is still considered a challenging 
research. In this manuscript, by focussing on HuR, owing to its high potential in cancer therapy and diagnosis48,49 
and in line with this observation, we studied the molecular recognition between natural ligands and the protein at 
the atomic level. We followed a systematic medicinal-chemistry approach based on structural biophysical studies 
by STD-NMR combined with molecular modelling. To properly explore the chemical space, we collected and 
selected a library of compounds of natural origin, applying structural diversity criteria.
The combined STD-NMR/molecular modelling approach allowed us to study the direct interactions between 
HuR and small molecules. By defining the ligand epitope of interaction and corroborating useful aspects about 
the protein conformational changes and HuR–ligand interactions, our findings represent a pivotal starting point 
to drive a drug discovery program. The preliminary SAR considerations drawn in this work will drive the design 
of a new ad hoc small focused compound library. In the near future, our efforts will be directed along this long 
and winding road.
Methods
Preliminary docking studies. The preliminary docking investigation on all 28 selected compounds was 
carried out as already described22.
Characterisation of the natural compounds, solubility and stability assessment. To assess the 
compound stability and solubility, 1H-NMR spectra were acquired on a 400 MHz Bruker Avance spectrometer 
using a 1 mM solution of each compound in a 20 mM deuterated phosphate buffer within a 5.0–7.4 pH range, and 
a 283–303 K temperature range; all occurring peak variations due to instability or solubility issues were monitored 
over time within a 48 h time period by acquiring 1H spectra at regular intervals; a DMSO-d6 percentage ≤10% 
was allowed to dissolve the less soluble compounds.
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The full compound characterisation at the optimised conditions (pH 5.8 or 7.4, DMSO-d6% and 283 K) was 
performed for the final 13 selected compounds and required the further acquisition and assignment of COSY, 
TOCSY, HSQC and NOESY spectra.
Protein expression and purification. Protein expression, purification and purity assessment for HuR 
aliquots utilised in the STD-NMR study were performed as already described23,50.
STD-NMR. All protein/ligand samples were prepared in a 1000:1 ligand/protein ratio. Typically, the final con-
centration of the samples was 400 μM of ligand and 0.4 μM of HuR, and the final volume was 500 μL. The buffer 
used is a 20 μM deuterated phosphate buffer with 10% H2O, pH 5.8 for compounds 1–3, 9, 10; pH 7.4 for 4–8, 
11–13; an additional amount of DMSO-d6 ≤ 10% was used to aid the solubility of compounds 4, 5, 7, 11 and 13.
1H–STD-NMR experiments were performed at 600 MHz on a Bruker Avance spectrometer. The probe tem-
perature was maintained at 283 K. In the STD experiments, water suppression was achieved by WATERGATE 
3–9–19 pulse sequence. The on-resonance irradiation of the protein was performed at a chemical shift of −0.05 
ppm for all compounds with the exception of compound 13 which was irradiated at –2.00 ppm to avoid artefacts. 
Off-resonance irradiation was applied at 200 ppm, where no protein signals are visible. Selective presaturation 
of the protein was achieved by a train of Gauss-shaped pulses of 49 ms length each. The STD-NMR spectra were 
acquired with varying saturation times from 0.98 s to 2.94 s; the optimised total length of the saturation train was 
2.94 s for all compounds except for compound 1 for which we analysed the STD experiment at 0.98 s due to its 
instability observed after longer experimental timeframes.
Intensities of all STD effects (absolute STD) were calculated by division through integrals over the respective 
signals in STD-NMR reference spectra. The different signal intensities of the individual protons are best analysed 
from the integral values in the reference and STD spectra, respectively. (I0 − Isat)/I0 is the fractional STD effect, 
expressing the signal intensity in the STD spectrum as a fraction of the intensity of an unsaturated reference spec-
trum. In this equation, I0 is the intensity of one signal in the off-resonance or reference NMR spectrum, Isat is the 
intensity of a signal in the on-resonance NMR spectrum, and I0 − Isat represents the intensity of the STD-NMR 
spectrum.
Molecular Dynamics and Docking simulations. Starting from the crystal structure of the two 
N-terminal RRM domains of HuR complexed with RNA, deposited in the Protein Data Bank (PDB) with 4ED5 
PDB code51, we performed our modelling simulations. The HuR-RNA complex was prepared through Protein 
Preparation Wizard implemented in Maestro using OLPS-2005 as force field52–54. Residual crystallographic buffer 
components and water molecules were removed, missing side chains were built using the Prime module55, hydro-
gen atoms were added, side chains protonation states at pH 7.4 were assigned. The structure was then submitted 
to 10000 of MacroModel minimisation steps using OPLS-2005 as force field54,56. Molecular Dynamics (MD) 
simulations were run using Desmond package v. 3.8 at 300 K temperature and ensamble NPT class57,58. The system 
was immersed in an orthorhombic box of TIP4P water molecules, extending at least 10 Å from the protein, and 
counter ions were added to neutralise the system charge. The resulting trajectory was clustered with respect to 
Root Mean Square Deviation (RMSD), in order to explore all the collection structures obtained, getting ten repre-
sentative structures, which were submitted to 10.000 MacroModel minimisation steps, using OLPS-2005 as force 
field. Docking studies were carried out with Glide, software by using SP v. 6.7 (standard precision) algorithm and 
the binding pocket was identified by placing a cube centred on the mRNA, 10 poses for ligand were generated59.
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